Literature DB >> 11485897

Complex regulation of telomerase activity: implications for cancer therapy.

K S Elenitoba-Johnson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11485897      PMCID： PMC1850547          DOI： 10.1016/S0002-9440(10)61710-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  71 in total

1.  Telomerase catalytic subunit homologs from fission yeast and human.

Authors:  T M Nakamura; G B Morin; K B Chapman; S L Weinrich; W H Andrews; J Lingner; C B Harley; T R Cech
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

2.  Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells.

Authors:  H Li; L L Zhao; J W Funder; J P Liu
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

3.  Telomere loss in cells treated with cisplatin.

Authors:  T Ishibashi; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

4.  Inhibition of telomerase limits the growth of human cancer cells.

Authors:  W C Hahn; S A Stewart; M W Brooks; S G York; E Eaton; A Kurachi; R L Beijersbergen; J H Knoll; M Meyerson; R A Weinberg
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

5.  Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.

Authors:  K Fujimoto; M Takahashi
Journal:  Biochem Biophys Res Commun       Date:  1997-12-29       Impact factor: 3.575

6.  Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase.

Authors:  C M Counter; M Meyerson; E N Eaton; L W Ellisen; S D Caddle; D A Haber; R A Weinberg
Journal:  Oncogene       Date:  1998-03-05       Impact factor: 9.867

7.  Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis.

Authors:  Y Kondo; S Kondo; Y Tanaka; T Haqqi; B P Barna; J K Cowell
Journal:  Oncogene       Date:  1998-04-30       Impact factor: 9.867

8.  Telomerase activity in relation to p53 status and clinico-pathological parameters in breast cancer.

Authors:  G Roos; P Nilsson; S Cajander; N H Nielsen; C Arnerlöv; G Landberg
Journal:  Int J Cancer       Date:  1998-08-21       Impact factor: 7.396

9.  Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence.

Authors:  I Horikawa; M Oshimura; J C Barrett
Journal:  Mol Carcinog       Date:  1998-06       Impact factor: 4.784

10.  Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.

Authors:  G A Ulaner; J F Hu; T H Vu; L C Giudice; A R Hoffman
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701
View more
  1 in total

1.  An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells.

Authors:  Oula El Atat; Diane Antonios; George Hilal; Nabil Hokayem; Joelle Abou-Ghoch; Hussein Hashim; Rim Serhal; Clara Hebbo; Mayssam Moussa; Nada Alaaeddine
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.